Pivotal Bioventure Partners Investment Advisor Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 13, 2026, Pivotal Bioventure Partners Investment Advisor Llc disclosed 13 stock positions valued at approximately $307.79M as of quarter-end June 30, 2026. The largest holdings include VAXCYTE INC, ARCUTIS BIOTHERAPEUTICS INC, and TREVI THERAPEUTICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 13
- Portfolio Value
- $307.79M
Holdings by Sector
Pivotal Bioventure Partners Investment Advisor Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| VAXCYTE INC | PCVX | Healthcare | 26.92% | 1,425,470 | +53,045 | +3.87% | $82,862,571 |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | Healthcare | 10.78% | 1,265,283 | -90,609 | -6.68% | $33,175,720 |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 10.56% | 1,742,672 | +188,946 | +12.16% | $32,500,833 |
| AVALYN PHARMACEUTICALS INC | AVLN | Healthcare | 10.34% | 966,792 | +966,792 | +100.00% | $31,826,793 |
| EVOMMUNE INC | EVMN | Healthcare | 8.32% | 1,926,943 | - | - | $25,609,072 |
| MAPLIGHT THERAPEUTICS INC | MPLT | Healthcare | 7.12% | 611,446 | -1 | -0.00% | $21,914,225 |
| OCULIS HOLDING AG | OCS | Healthcare | 6.79% | 1,506,250 | -174,033 | -10.36% | $20,891,688 |
| BIOAGE LABS INC | BIOA | Healthcare | 5.20% | 653,374 | - | - | $16,014,197 |
| IMMUNOME INC | IMNM | Healthcare | 5.04% | 732,512 | - | - | $15,521,929 |
| ZENAS BIOPHARMA INC | ZBIO | Healthcare | 4.05% | 490,766 | -101,225 | -17.10% | $12,455,641 |
| AVALO THERAPEUTICS INC | AVTX | Healthcare | 2.61% | 434,033 | +138,100 | +46.67% | $8,020,930 |
| RALLYBIO CORP | RLYB | Healthcare | 1.56% | 300,579 | - | - | $4,809,264 |
| RECURSION PHARMACEUTICALS IN | RXRX | Healthcare | 0.71% | 595,518 | - | - | $2,185,551 |
Showing 13 of 13 holdings in the latest reporting period.